The shift to a pay-for-performance environment healthcare gets the provider more involved with the patient, which has a greater impact on quality measures like adherence, said Mitzi Wasik, PharmD, BCPS, director of Pharmacy Medicare Programs at Aetna, Inc.
The shift to a pay-for-performance environment healthcare gets the provider more involved with the patient, which has a greater impact on quality measures like adherence, said Mitzi Wasik, PharmD, BCPS, director of Pharmacy Medicare Programs at Aetna, Inc.
Transcript (slightly modified for readability)
How does pay-for-performance support the accountability of patient care?
The fact that we’re shifting away from a “do more, pay more” type philosophy should get the providers engaged and wanting to do more with their patients, because we’re paying for the quality, not the quantity.
The provider may not get paid for the actual time they spent counseling, but if they’re reimbursed for the adherence to the medication by the patient at the end of the year, or whatever the timeframe is, then they’re more likely to be involved with that patient. And historically, if a patient is seeing a physician, the physician will ask, “Are you taking your medications” and there’s so much going on and so little time for the physician to actually work with the patient, that they may not know that the patient missed 2 weeks of their medication and tying that to adherence at the end of the year, they might be more apt to ask those types of questions and build it more into the practice.
And at the end of the day it comes down to the physician influence. So if a patient gets a call from a health insurer or PBM, they don’t have that personal relationship, whereas if a physician, or a physician staff that they know well, is calling them and asking them about their adherence behaviors, they are more likely to feel like they got sent to the principal’s office, and they are more likely to continue to take their medication and have that open discussion with their physician. And I think the physician influence is key in all of these metrics that we’re looking at in quality, and they really are the pinnacle of getting the patients to a healthier place.
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen